Abstract:There is evidence that ischemic stroke is the most common type of clinical cerebrovascular disease and inflammation plays a critical role in the pathogenesis of ischemic stroke. As an inducer of Th2 immune responses, IL-33, a novel member of the IL-1 cytokine family, has pleiotropic effects on immune responses via IL- 33/ST2 signaling pathway. In recent years, IL-33 and its signaling pathway have attracted wide attention in the field of ischemic stroke pathogenesis, and it has been considered as a new target for alleviating the inflammation caused by ischemic brain injury. The generation of IL-33/ST2 signaling pathway and its physiological function in ischemic stroke were discussed, and the latest research progress was also introduced in this paper.